{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:34:57Z","timestamp":1761766497367,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.lungcan.2018.11.032","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T12:31:30Z","timestamp":1543235490000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group"],"prefix":"10.1016","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9733-5442","authenticated-orcid":false,"given":"David B.","family":"Chapel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Santoni-Rugiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya N.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"May (5)","key":"10.1016\/j.lungcan.2018.11.032_bib0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"November (12)","key":"10.1016\/j.lungcan.2018.11.032_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/1742-6413.170726","volume":"30","author":"Hjerpe","year":"2015","journal-title":"Cytojournal"},{"issue":"January (1)","key":"10.1016\/j.lungcan.2018.11.032_bib0015","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"October (4)","key":"10.1016\/j.lungcan.2018.11.032_bib0020","first-page":"1122","article-title":"A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group","volume":"108","author":"Rusch","year":"1995","journal-title":"Chest"},{"issue":"August (8)","key":"10.1016\/j.lungcan.2018.11.032_bib0025","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/JTO.0b013e3182208e3f","volume":"6","author":"Rice","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"November","key":"10.1016\/j.lungcan.2018.11.032_bib0030","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.lungcan.2016.09.003","article-title":"Imaging in pleural mesothelioma: a review of the 13th International Conference of the International Mesothelioma Interest Group","volume":"101","author":"Armato","year":"2016","journal-title":"Lung Cancer"},{"issue":"May (6)","key":"10.1016\/j.lungcan.2018.11.032_bib0035","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/his.13468","article-title":"Malignant mesothelioma in situ","volume":"72","author":"Churg","year":"2018","journal-title":"Histopathology"},{"issue":"February (2)","key":"10.1016\/j.lungcan.2018.11.032_bib0040","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/modpathol.2011.146","article-title":"A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma","volume":"25","author":"Kadota","year":"2012","journal-title":"Mod. Pathol."},{"issue":"April (4)","key":"10.1016\/j.lungcan.2018.11.032_bib0045","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/modpathol.2017.170","article-title":"Nuclear grade and necrosis predict prognosis in malignant epithelioid pleural mesothelioma: a multi-institutional study","volume":"31","author":"Rosen","year":"2018","journal-title":"Mod. Pathol."},{"issue":"August (8)","key":"10.1016\/j.lungcan.2018.11.032_bib0050","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"issue":"February","key":"10.1016\/j.lungcan.2018.11.032_bib0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: Comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"issue":"September","key":"10.1016\/j.lungcan.2018.11.032_bib0060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.humpath.2016.04.015","article-title":"Genomic copy number alterations in 33 malignant peritoneal mesothelioma analyzed by comparative genomic hybridization array","volume":"55","author":"Chirac","year":"2016","journal-title":"Hum. Pathol."},{"issue":"May (5)","key":"10.1016\/j.lungcan.2018.11.032_bib0065","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","article-title":"The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)","volume":"23","author":"Kusamura","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"August (4)","key":"10.1016\/j.lungcan.2018.11.032_bib0070","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","article-title":"Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma","volume":"38","author":"Pillai","year":"2015","journal-title":"Am. J. Clin. Oncol."},{"issue":"December (7)","key":"10.1016\/j.lungcan.2018.11.032_bib0075","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/PAT.0000000000000181","article-title":"Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients","volume":"46","author":"Liu","year":"2014","journal-title":"Pathology"},{"issue":"September (9)","key":"10.1016\/j.lungcan.2018.11.032_bib0080","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/14737140.2016.1220305","article-title":"Preventing recurrence of diffuse malignant peritoneal mesothelioma","volume":"16","author":"Leinwand","year":"2016","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"4","key":"10.1016\/j.lungcan.2018.11.032_bib0085","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4149\/neo_2014_053","article-title":"Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma","volume":"61","author":"Kaya","year":"2014","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.lungcan.2018.11.032_bib0090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nm.1918","article-title":"Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway","volume":"15","author":"Kleaveland","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0095","doi-asserted-by":"crossref","first-page":"45768","DOI":"10.1038\/srep45768","article-title":"HEG1 is a novel mucin-like membrane protein that serves as a diagnostic and therapeutic target for malignant mesothelioma","volume":"7","author":"Tsuji","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.lungcan.2018.11.032_bib0100","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.humpath.2015.06.024","article-title":"BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma","volume":"46","author":"McGregor","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/JTO.0b013e3182417da5","article-title":"Plasma cell membrane localization of c-MET predicts longer survival in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group","volume":"7","author":"Levallet","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.anndiagpath.2016.04.007","article-title":"c-Met expression and MET amplification in malignant pleural mesothelioma","volume":"23","author":"Bois","year":"2016","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0115","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/j.jtho.2017.03.015","article-title":"FISH Analysis of Crizotinib Target GenesROS1\/ALK\/MET in Malignant Mesothelioma","volume":"12","author":"Salvi","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1158\/1078-0432.CCR-14-0450","article-title":"MET amplification status in therapy-na\u00efve adeno- and squamous cell carcinomas of the lung","volume":"21","author":"Schildhaus","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0125","doi-asserted-by":"crossref","first-page":"26195","DOI":"10.18632\/oncotarget.25490","article-title":"Concomitant driver mutations in advanced EGFR-mutated non-small-cell lung cancer and their impact on erlotinib treatment","volume":"9","author":"Jakobsen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.lungcan.2018.11.032_bib0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc.2016.83","article-title":"Maintaining cell identity: PRC2-mediated regulation of transcription and cancer","volume":"16","author":"Comet","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lungcan.2018.11.032_bib0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.lungcan.2018.11.032_bib0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat. Med."},{"issue":"July","key":"10.1016\/j.lungcan.2018.11.032_bib0145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.lungcan.2017.03.005","article-title":"Targeting BAP1: a new paradigm for mesothelioma","volume":"109","author":"Schunselaar","year":"2017","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218306718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500218306718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:25:28Z","timestamp":1759235128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500218306718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":29,"alternative-id":["S0169500218306718"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.032","relation":{},"ISSN":["0169-5002"],"issn-type":[{"type":"print","value":"0169-5002"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathways and diagnosis in malignant mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2018.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}